Fuji Pharma Co., Ltd. (TYO:4554)

Market Cap	48.50B +20.1%
Revenue (ttm)	62.39B +20.7%
Net Income	2.83B -5.6%
EPS	111.18 -9.6%
Shares Out	26.12M
PE Ratio	16.70
Forward PE	10.23
Dividend	49.00 (2.64%)
Ex-Dividend Date	Sep 29, 2026

Volume	160,800
Open	1,877.00
Previous Close	1,878.00
Day's Range	1,838.00 - 1,881.00
52-Week Range	1,638.00 - 2,559.00
Beta	0.33
Analysts	Buy
Price Target	2,950.00 (+58.86%)
Earnings Date	Nov 10, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 1,760
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4554

Financial Performance

In fiscal year 2026, Fuji Pharma's revenue was 62.39 billion, an increase of 20.72% compared to the previous year's 51.68 billion. Earnings were 2.83 billion, a decrease of -5.63%.

Analyst Summary

According to 2 analysts, the average rating for 4554 stock is "Buy." The 12-month stock price target is ¥2,950, which is an increase of 58.86% from the latest price.

Price Target

¥2,950

(58.86% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error